Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001737287-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,875,786
Total Value
$171,484.20
P&L
+inf% (+$3,685,670.19)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Sale | 95,269 | $1.80 | $171,484.20 | 5,185,862 | Direct | โ | View Details | |
Director | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 1,387,931 | $0.00 | $0.00 | 1,387,931 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 392,586 | $0.00 | $0.00 | 392,586 | Direct | โ | View Details |